Application deadline: 24 Jul 2019 16:00 BST
The South African Medical Research Council (SAMRC) has an opportunity to partner with the Government of Switzerland via the Swiss Vaccine Research Institute and the University of Lausanne in a capacity development programme in the research field of Vaccine Development.
The University of Lausanne (UNIL) is offering an International Masters in Vaccinology (IMVACC) developed by the Swiss Vaccine Research Institute (SVRI) and the Health Sciences e-Training Foundation (HSeT) in collaboration with the Lausanne University Hospital (CHUV).
This is an e-learning facilitated programme with the University of Lausanne funded jointly with the SAMRC. More information about this Masters programme can be found at http://imvacc.bio-med.ch/cms/
The SAMRC is inviting submissions of CVs, accompanied by certified copies of academic qualifications and South African ID as well as a letter (not more than one page) of motivation for the SAMRC to consider for the scholarship award.
Qualifying individuals must be South African citizens, preferably from designated priority population groups or institutions. The individuals must hold at least an MBChB or PhD in Clinical/Health research. The successful candidates will be funded for a period of two years.
Applications will be submitted to the Scholarships & Grants Applications Review Committee for consideration and recommendation for funding.
For more information or to apply visit the call website.